The new era of data informatics tools can help providers and payers understand the tiers of risk that determine the economics of care delivery, which is crucial to value-based cancer treatment, according to Joseph Alvarnas, MD, of the City of Hope and editor-in-chief of Evidence-Based Oncology
The new era of data informatics tools can help providers and payers understand the tiers of risk that determine the economics of care delivery, which is crucial to value-based cancer treatment, according to Joseph Alvarnas, MD, of the City of Hope and editor-in-chief of Evidence-Based Oncology.
Transcript (slightly modified)
Patients with more advanced disease could result in higher costs and worse outcomes. Do risk-based payment models account for this?
So you’re kind of talking to an area that I find fascinating. In my current role at the City of Hope I work as the director of value-based analytics, and part of that is trying to figure out the global cost of care, but I think the other part of it, which I think is the key to mastering economic sustainability, particularly at academic cancer centers, is understanding how clinical risk translates into the cost of care delivery.
I think when we engage payers on these issues of value, if we look simply at a blanket diagnosis then we do a disservice both to the payer and to ourselves. Our value proposition is predicated upon really understanding the cost structure of delivering care, and understanding the, I would say, deep-seated connections between someone’s genomics, someone’s proteomics, the nature of their cancer, their comorbidities, so that we can talk more meaningfully about this patient and their projected cost of care.
So I think ultimately what we have to look toward is as we can leverage this enormously powerful era of data informatics to understand the tiers of risk within a particular diagnosis, I think you get both physicians and healthcare systems as well as payers into a different mindset of how best to model the economics of care delivery, and probably can serve as the basis for the creative development of new risk-based payment schemes.
Untangling Medical Debt From Credit Scores: Effects So Far and Next Steps
November 29th 2023After recent policy changes removing most medical debts from credit reports, Americans are seeing their credit scores increase, but experts warn of the need to monitor billing and collection practices for unintended consequences.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Lawsuits target initiatives aimed at reducing racial disparities; less than 10% of trials for COVID-19 treatments included children in the first 3 years of the pandemic; the World Health Organization requests more information on increased respiratory illnesses in China.
Read More
Allegations call out restrictions on medically necessary care; CDC data highlight surge in COVID-19 deaths and hospitalizations; failure to include additional Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) aid raises concerns over food access.
Read More